Entia Liberty: Home Study

About this trial

Last updated 2 years ago

Study ID

317614

Status

Completed

Type

Observational

Placebo

Accepting

18+ Years

All Sexes

Trial Timing

Ended 2 years ago

What is this trial about?

Participants will be testing with the home monitoring device over the course of their treatment. They are to self-test on days where they are due to be going into hospital for their routine pre-treatment blood tests. Participants will be asked to fill in interim questionnaires and a final questionnaire to answer the study objectives.

What are the participation requirements?

Inclusion Criteria

* Age ≥ 18

* Adequate English language skills (not requiring a translator) to participate in participant training and use the Liberty device

* Patients willing and able to perform capillary blood self-testing at the same frequency as routine full blood count monitoring

* Patients capable of providing informed consent before attending training

* Patients able to attend a 1-hour virtual training session within 2 weeks of joining the study

* Patients with a home Wi-Fi network or with adequate coverage at home via a 4G network

* Patients with access to a laptop or smartphone to facilitate training

* Patients with a diagnosis of ovarian or breast cancer

* Patients whose HCPs can confirm are undergoing systemic anti-cancer treatments within two weeks of enrolment, with treatment expected to continue for at least two cycles

Exclusion Criteria

* Patients with haematological malignancies

* Patients with eyesight or hearing limitations or other disabilities that preclude the use of the Liberty device or participation in training unless they have a nominated caregiver who is capable of assisting with each test